FDA authorizes updated COVID booster for children aged 5-11
The U.S. Food and Drug Administration on Wednesday authorized Omicron-tailored COVID-19 booster shots from Moderna Inc as well as Pfizer Inc and its partner BioNTech SE for children, a move that will boost the government's fall vaccination campaign.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.